165 related articles for article (PubMed ID: 25794661)
41. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
42. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
[TBL] [Abstract][Full Text] [Related]
43. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
Gu L; Xie L; Zuo C; Ma Z; Zhang Y; Zhu Y; Gao J
BMC Cancer; 2015 Jul; 15():529. PubMed ID: 26189041
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs.
Kawamoto K; Pahuja A; Hering BJ; Bansal-Pakala P
Transpl Immunol; 2010 May; 23(1-2):28-33. PubMed ID: 20307666
[TBL] [Abstract][Full Text] [Related]
45. [Can defective TGF-Beta signaling be an Achilles heel in human cancer?].
Foster DA; Gadir N
Ai Zheng; 2008 Aug; 27(8):882-4. PubMed ID: 18710627
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells.
Miles FL; Kurtoglu S; Ahmer C; Soori M; Favate JS; Sikes RA
Prostate; 2015 Nov; 75(15):1802-13. PubMed ID: 26392321
[TBL] [Abstract][Full Text] [Related]
47. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
Inman GJ; Allday MJ
J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
[TBL] [Abstract][Full Text] [Related]
48. TGF-beta1/SMAD signaling pathway mediates p53-dependent apoptosis in hepatoma cell lines.
Wang CL; Wan YL; Liu YC; Huang ZQ
Chin Med Sci J; 2006 Mar; 21(1):33-5. PubMed ID: 16615282
[TBL] [Abstract][Full Text] [Related]
49. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
50. Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.
Márk Á; Hajdu M; Váradi Z; Sticz TB; Nagy N; Csomor J; Berczi L; Varga V; Csóka M; Kopper L; Sebestyén A
BMC Cancer; 2013 May; 13():250. PubMed ID: 23693095
[TBL] [Abstract][Full Text] [Related]
51. Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
Kao YH; Jawan B; Goto S; Pan MC; Lin YC; Sun CK; Hsu LW; Tai MH; Cheng YF; Nakano T; Wang CS; Huang CJ; Chen CL
Cytokine; 2009 Jul; 47(1):11-22. PubMed ID: 19457680
[TBL] [Abstract][Full Text] [Related]
52. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
[TBL] [Abstract][Full Text] [Related]
53. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta type I receptor/ALK5 contributes to doxazosin-induced apoptosis in H9C2 cells.
Yang YF; Wu CC; Chen WP; Su MJ
Naunyn Schmiedebergs Arch Pharmacol; 2009 Dec; 380(6):561-7. PubMed ID: 19727674
[TBL] [Abstract][Full Text] [Related]
55. Anti-apoptotic effect of transforming growth factor-beta1 on human articular chondrocytes: role of protein phosphatase 2A.
Lires-Deán M; Caramés B; Cillero-Pastor B; Galdo F; López-Armada MJ; Blanco FJ
Osteoarthritis Cartilage; 2008 Nov; 16(11):1370-8. PubMed ID: 18495502
[TBL] [Abstract][Full Text] [Related]
56. mTOR inhibition by rapamycin increases ceramide synthesis by promoting transforming growth factor-β1/Smad signaling in the skin.
Yamane T; Muramatsu A; Yoshino S; Matsui S; Shimura M; Tsujii Y; Iwatsuki K; Kobayashi-Hattori K; Oishi Y
FEBS Open Bio; 2016 Apr; 6(4):317-25. PubMed ID: 27239444
[TBL] [Abstract][Full Text] [Related]
57. Soy peptide-induced stem cell proliferation: involvement of ERK and TGF-β1.
Lee J; Roh KB; Kim SC; Lee J; Park D
J Nutr Biochem; 2012 Oct; 23(10):1341-51. PubMed ID: 22217516
[TBL] [Abstract][Full Text] [Related]
58. Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.
Park Y; Kim W; Lee JM; Park J; Cho JK; Pang K; Lee J; Kim D; Park SW; Yang KM; Kim SJ
Oncogene; 2015 Sep; 34(39):5037-45. PubMed ID: 25531329
[TBL] [Abstract][Full Text] [Related]
59. Effect of exogenous TGF-β1 on the cadmium-induced nephrotoxicity by inhibiting apoptosis of proximal tubular cells through PI3K-AKT-mTOR signaling pathway.
Huang M; Su L; Yang L; Zhu L; Liu Z; Duan R
Chem Biol Interact; 2017 May; 269():25-32. PubMed ID: 28342888
[TBL] [Abstract][Full Text] [Related]
60. [Blockage of mTOR signaling pathway by rapamycin contributes to inhibition of tumor cell proliferation in ALK-positive lymphoid cell strains].
Gu L; Li JF; Gao J; Zhu YP; Li Q; Jia CS; Zhou CY; Ma ZG
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):662-6. PubMed ID: 19176057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
